-
Mashup Score: 0
The PillSense System, a novel blood-sensing swallowed capsule device, safely detected blood in patients with clinically suspected upper gastrointestinal bleeding with a sensitivity of 92.9% and a specificity of 90.6%, data showed. “[Esophagogastroduodenoscopy] is now considered the gold standard for diagnosing and treating [upper GI bleeding (UGIB)], although timely diagnosis and
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 2CrowdWisdom - 5 month(s) ago
CrowdWisdom 0.6.32
Source: agau.gastro.orgCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 2CrowdWisdom - 6 month(s) ago
CrowdWisdom 0.6.32
Source: agau.gastro.orgCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 2CrowdWisdom - 6 month(s) ago
CrowdWisdom 0.6.32
Source: agau.gastro.orgCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 2CrowdWisdom - 6 month(s) ago
CrowdWisdom 0.6.32
Source: agau.gastro.orgCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 0
Each year, as part of the Medicare physician fee schedule policy changes, the CMS is required to include administrative burden estimates for complying with Merit-based Incentive Payment System reporting. In the recent 2024 Medicare physician fee schedule proposed rule, CMS proposed the following estimates for each Merit-based Incentive Payment System (MIPS) performance category:
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 0
Each year, as part of the Medicare physician fee schedule policy changes, the CMS is required to include administrative burden estimates for complying with Merit-based Incentive Payment System reporting. In the recent 2024 Medicare physician fee schedule proposed rule, CMS proposed the following estimates for each Merit-based Incentive Payment System (MIPS) performance category:
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 0VIDEO: Tremfya maintains clinical, endoscopic efficacy through 3 years in Crohn’s disease - 7 month(s) ago
In a Healio video exclusive, Jan Wehkamp, MD, PhD, reports that treatment with Tremfya maintained clinical remission and endoscopic response through 3 years among patients with moderate to severe Crohn’s disease. “There is still tremendous unmet need for patients with inflammatory bowel diseases such as Crohn’s disease and ulcerative colitis,” Wehkamp, vice president and
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 02024 AGA leadership nominations are open - 7 month(s) ago
Submit yourself, or a peer, for an open AGA leadership role through the fall.
Source: gastro.orgCategories: Gastroenterology, Latest HeadlinesTweet-
Interested in building education programs focused on the most pressing issues in #GI? Nominate yourself or a peer for the #AGA Institute Council, AGA’s committees or to serve as one of AGA’s course directors. Nominations are being accepted through Nov. 1. https://t.co/ERrl15em8N https://t.co/lWMs8vNPT6
-
-
Mashup Score: 3Fecal transplant ‘not over yet’ for C. difficile despite boom in live microbiota therapies - 7 month(s) ago
Clostridioides difficile infection presents a unique treatment paradox for clinicians: Antibiotics are often both its cause and its cure.The broad-spectrum antibiotics doled out to treat infections also radically alter the composition of the microbiota, wiping out a significant portion of the bacterial community and upsetting the natural balance of gut flora. Without competition from healthy
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet
According to data 📈 from @GIE_Journal: The PillSense System safely detected blood in patients with clinically suspected upper #GI bleeding 🩸 with a sensitivity of 92.9% and a specificity of 90.6%, data showed. 👇🏼👇🏼 https://t.co/DSn8L3kz5y